Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.
Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T. Tsuji H, et al. Among authors: sugiyama e. Arthritis Rheumatol. 2020 Mar;72(3):488-498. doi: 10.1002/art.41105. Epub 2020 Jan 27. Arthritis Rheumatol. 2020. PMID: 31524333
C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.
Yoshida Y, Sugimoto T, Hosokawa Y, Suma H, Kobayashi H, Ishitoku M, Kohno H, Tokunaga T, Watanabe H, Mokuda S, Nojima T, Hirata S, Sugiyama E. Yoshida Y, et al. Among authors: sugiyama e. Mod Rheumatol. 2022 Jan 5;32(1):141-148. doi: 10.1080/14397595.2021.1907014. Mod Rheumatol. 2022. PMID: 33775207
[No title available]
[No authors listed] [No authors listed] PMID: 34922405
The clinical characteristics and predictors of severe digital ischemia in patients with anti-aminoacyl transfer RNA synthetase antibodies.
Suma H, Yoshida Y, Sugimoto T, Matsuo Y, Law SM, Nakashima R, Kobayashi H, Hosokawa Y, Ishitoku M, Kohno H, Watanabe H, Tokunaga T, Mokuda S, Nojima T, Hirata S, Sugiyama E. Suma H, et al. Among authors: sugiyama e. J Dermatol. 2021 Jul;48(7):1044-1051. doi: 10.1111/1346-8138.15884. Epub 2021 Apr 13. J Dermatol. 2021. PMID: 33847003 Review.
Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis.
Nakanishi Y, Yamaguchi K, Yoshida Y, Sakamoto S, Horimasu Y, Masuda T, Nakashima T, Miyamoto S, Iwamoto H, Hirata S, Fujitaka K, Hamada H, Sugiyama E, Hattori N. Nakanishi Y, et al. Among authors: sugiyama e. Intern Med. 2020 Oct 15;59(20):2553-2558. doi: 10.2169/internalmedicine.4702-20. Epub 2020 Jun 23. Intern Med. 2020. PMID: 32581161 Free PMC article.
374 results